understanding cancer current scientific research on causes treatments and prevention
Download
Skip this Video
Download Presentation
Cancer Treatments and Prevention

Loading in 2 Seconds...

play fullscreen
1 / 136

Cancer Treatments and Prevention - PowerPoint PPT Presentation


  • 576 Views
  • Uploaded on

Advanced research on the causes, treatments, and prevention of cancer. This video shows how to use research tools to get advancements in diagnostics, treatment and nutrition (nutraceuticals) in order to optimize your fight against cancer.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Cancer Treatments and Prevention' - Cancer


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
understanding cancer current scientific research on causes treatments and prevention
Understanding Cancer: Current Scientific Research on Causes, Treatments, and Prevention

www.ctoam.com

slide2

Our mission is to educate you and provide you with the most current research on the prevention and treatment of cancer so that you can make the most informed choice possible and ensure that you are doing all you can to have a life that is cancer free.

www.ctoam.com

slide3
This presentation will cover key aspects of cancer development and treatment based on current scientific knowledge.

www.ctoam.com

slide4

It is our gift to you because we know that the more education and understanding you have, the better able you will be to make sure you are receiving the most effective treatment possible.

www.ctoam.com

a little about us
A Little About Us

CTOAM provides personalized research and support for all aspects of cancer treatment.

www.ctoam.com

a little about us6
A Little About Us

We explore the underlying genetics involved in your cancer and incorporate cutting edge, scientifically proven, treatment options with a personalized, genetically based, nutritional approach.

www.ctoam.com

a little about us7
A Little About Us

The combination of personalized research, cutting edge proven treatments, and nutraceutical treatment provides our patients with the greatest chance for complete recovery.

www.ctoam.com

a little about us8
A Little About Us

This presentation will help you to understand why personalized cancer research and nutraceuticals are fundamental to your treatment, recovery, and longevity, and how you can most simply and effectively implement this information.

www.ctoam.com

a little about us9
A Little About Us

At CTOAM we use only the most current, peer reviewed scientific data to conduct personalized cancer research for you.

This means that you can trust that the material in this presentation and in our Personalized Options Reports is based on solid science (with references supplied).

www.ctoam.com

feel free to share
Feel Free to Share

We know you’ll learn a lot from this presentation and we welcome hearing your questions and thoughts. Please feel free to share it with your friends, family, support groups and medical support team.

Alex Rolland, CEO

www.ctoam.com

in this presentation we ll cover
In This Presentation We’ll Cover:
  • How cancer develops and the role of genes and stem cells in its development.
  • Current treatments, their effectiveness and limitations.

www.ctoam.com

in this presentation we ll cover12
In This Presentation We’ll Cover:
  • Diagnostic and imaging options that have been proven to enhance treatment effectiveness.
  • The benefits and misconceptions of clinical trials.

www.ctoam.com

in this presentation we ll cover13
In This Presentation We’ll Cover:

The importance of using nutraceuticals as part of your cancer treatment and prevention protocol.

www.ctoam.com

this presentation consists of two key sections
This presentation consists of two key sections:

1. Cancer 101 (Understanding current issues in cancer)

&

2. Ensuring That You Are Making Informed Choices

www.ctoam.com

cancer 101
Cancer 101

It is now widely accepted that all cancers

are caused by adult stem cells (or cells with

stem-cell like properties).

www.ctoam.com

what is an adult stem cell
What is an adult stem cell?
  • Adult stem cells occur in roughly 1 out of 6 million body cells.
  • These cells are used to repair and replace body cells.

www.ctoam.com

cancer 10117
Cancer 101

Adult stem cells are different from

embryonic stem cells in a few ways:

Adult stem cells are contained in regions referred to as stem cell niches, where they remain in a dormant state (quiescence) until activated.

Each type of tissue contains it’s own stem cell niche.

www.ctoam.com

cancer 10118
Cancer 101

Adult stem cells are different from

embryonic stem cells in a few ways:

Unlike embryonic stem cells, adult stem cells are restricted to producing cells of a specific tissue type.

www.ctoam.com

what is an adult stem cell19
What is an adult stem cell?
  • All stem cells have unique features that allow them to avoid destruction during treatment.
  • However, it is their ability to exist in a dormant state (quiescence) until activated, that is currently inhibiting standard treatments.

www.ctoam.com

the 2 stages of stem cell activation
The 2 stages of stem cell activation

There are two key stages of stem cell

activation:

  • Proliferation &
  • Differentiation.

www.ctoam.com

the 2 stages of stem cell activation21
The 2 stages of stem cell activation

In The Proliferation Stage:

The stem cell makes multiple copies of itself.

In The Differentiation Stage:

The multiple copies are converted into the

required cell type and given a Hayflick

number.

www.ctoam.com

the 2 stages of stem cell activation22
The 2 stages of stem cell activation
  • The Hayflick number is the number of times a normal cell will divide before it stops and dies.
  • The important point here is that once a cell has differentiated, it has a finite lifespan.

www.ctoam.com

stem cell life cycle
Stem cell life cycle

Stem cell

(dormant)

Progenitor cell

(proliferation)

Mature cell

(differentiation)

(Activation)

Self renewal

www.ctoam.com

stem cell life cycle24
Stem cell life cycle
  • There are two imports points here:
  • A stem cell makes an exact copy of itself, which remains dormant in the stem cell niche.
  • A stem cell also produces a large amount of progenitor cells, which then differentiate into the required type of cells.

www.ctoam.com

stem cells and cancer
Stem cells and cancer

The problem with stem cells is that sometimes, due to mutations, a stem cell is not provided with the cues for differentiation and it gets stuck in a never ending cycle of proliferation, making many copies of itself.

This is what we call cancer.

www.ctoam.com

genes and cancer
Genes and cancer

Knowing what genes are involved in your cancer is fundamental to effective treatment because it is your genes that directly control the proliferation and differentiation of your stem cells.

www.ctoam.com

genes and cancer27
Genes and cancer

Mutations in the genes that control stem cell activation, proliferation and differentiation are responsible for your cancer.

www.ctoam.com

genes and cancer28
Genes and cancer

There are two key types of genes involved

in cancer:

1. Oncogenes.

&

2. Tumor suppressors.

www.ctoam.com

genes and cancer29
Genes and cancer

Oncogenes (tumor causing genes):

  • Cause proliferation.

2. Are turned on (expressed) or over-expressed in cancers.

3. Are mutated in such a way that causes them to stay on.

www.ctoam.com

genes and cancer30
Genes and cancer

Tumor suppressors (cancer preventing genes):

  • Initiate differentiation.
  • Are inhibited or under-expressed in cancers.
  • There are common mutations and deletions of tumor suppressors that occur in specific forms of cancer.

www.ctoam.com

genes and cancer31
Genes and cancer

The following image shows the healthy development of a stem cell into a mature, differentiated cell that has a finite life span.

This is the way things are supposed to go. (Notice the location of oncogenes and tumor suppressor genes – in red).

www.ctoam.com

normal stem cell life cycle
Normal stem cell life cycle

Stem cell

(dormant)

Progenitor cell

(proliferation)

Mature cell

(differentiation)

(Activation)

(Oncogenes)

(Tumor supressor genes)

Self renewal

www.ctoam.com

stem cells and cancer33
Stem cells and cancer

Recall that when a stem cell is not provided with the cues for differentiation, it gets stuck in a never ending cycle of proliferation, making many copies of itself and causing cancer.

The following slide shows what happens when this is the case.

www.ctoam.com

cancer stem cell life cycle
Cancer stem cell life cycle

Stem cell

(dormant)

Progenitor cell

(proliferation)

Mature cell

(differentiation)

(Activation)

(Oncogenes)

(Tumor suppressor genes)

Self renewal

Tumor cells

www.ctoam.com

stem cells and cancer35
Stem cells and cancer

You will notice in the previous image, that the tumor suppressor genes (which we need to prevent oncogenes from flourishing) are either non-existent or diminished or mutated to the point of ineffectiveness, thus giving the oncogenes free reign to trigger stem cells to proliferate and cause cancer.

www.ctoam.com

why is this important
Why is this important?

There are hundreds of documented oncogenes and tumor suppressor genes in your body.

Only four of these genes need to be altered or mutated for cancer to develop.

www.ctoam.com

why is this important37
Why is this important?

Therefore, there are many 1000’s of possible combinations of gene alterations that can lead to cancer in each individual case. It is not the same for every person.

This is why success rates for treatment can vary so greatly from one person to another.

www.ctoam.com

why is this important38
Why is this important?

It is also why a one size fits all approach to cancer treatment does not work.

You need to be engaged in a comprehensive treatment program that is going to attend to the specific genes and mutations involved in the development of your cancer so that you resolve the underlying cause of your cancer and not just treat the symptoms of tumors and proliferating cancer cells.

www.ctoam.com

why is this important39
Why is this important?

Standard medical treatments typically attempt to remove tumors or reduce the number of cancer cells in your body but are often unable to eradicate cancers at the level of oncogenes.

Nor are they able to enhance or repair the function of your tumor suppressor genes. This is why so many cancers return.

www.ctoam.com

why is this important40
Why is this important?

Ensuring that you are engaging in treatments that, as much as possible, target the genes specific to the development of your cancer, is key to reducing the side effects of treatment and enhancing life expectancy and cure rates.

This is our mission and area of expertise.

www.ctoam.com

development of cancer
Development of cancer

Now let’s explore how cancer develops once the unregulated proliferation of stem cells has begun.

www.ctoam.com

development of cancer42
Development of cancer

It is widely assumed that the originator stem cells that produce the bulk of a tumor are also responsible for metastasis.

When a cancer cell is stuck in proliferation and hasn’t differentiated, it can live almost anywhere in the body (metastasize).

www.ctoam.com

metastasis
Metastasis

But, how is it that cancer cells travel

throughout the body?

One way is through the blood vessels.

www.ctoam.com

angiogenesis and metastasis
Angiogenesis and metastasis

Cancer cells are constantly growing and therefore, need to consume a lot of resources. In other words, they require their own blood supply.

Angiogenesis is a process that cancers use to recruit their own blood vessels in order to enable their continued growth.

www.ctoam.com

angiogenesis and metastasis45
Angiogenesis and metastasis

The process of angiogenesis is controlled by oncogenes and tumor suppressor genes.

Oncogenes are responsible for the development of angiogenesis while tumor suppressor genes inhibit it.

www.ctoam.com

summary
Summary

Let’s review what we’ve covered so far about the development of cancer and then move on to an exploration of standard and enhanced treatment options.

www.ctoam.com

summary47
Summary
  • Stem cells remain dormant until activated.
  • Cancer is a disease of the stem cells caused by reduced differentiation and increased proliferation.

www.ctoam.com

summary48
Summary

Proliferation, differentiation, and angiogenesis are all controlled by genes.

The recruitment of blood vessels (angiogenesis) allows the tumor to grow and to metastasize.

www.ctoam.com

standard treatment methods
Standard treatment methods

Now let’s explore standard treatments to cancer, their pros and cons, and how you can enhance standard treatment and explore scientifically based adjunct therapies to increase your survival potential, reduce the likelihood of relapse and decrease any treatment side effects.

www.ctoam.com

slide50
The standardized approach to cancer treatment

utilizes the following three techniques:

Surgery: Removes diseased tissues.

2. Radiation: Creates DNA mutations in rapidly dividing cells.

3. Chemotherapy: Chemical interference of rapidly dividing cells.

Standard treatment methods

www.ctoam.com

limitations of surgery
Limitations of surgery
  • Surgery is localized:
  • Limited to treatment of localized disease.
  • This means there is the great potential to miss stem cells, cells that are in pre-cancerous stages, or cells that have already metastasized.

www.ctoam.com

limitations of radiation
Limitations of radiation

Radiation is localized:

  • Since it is non-selective and affects all rapidly dividing cells, radiation is very toxic.
  • Radiation only affects active cells during course of treatment (not dormant cancer causing stem cells).

www.ctoam.com

limitations of radiation53
Limitations of radiation

Radiation is localized:

Angiogenesis (cancer cell recruitment of blood vessels) occurs directly after treatment.

Radiation can create new DNA mutations that may lead to new cancers.

www.ctoam.com

limitations of chemotherapy
Limitations of chemotherapy

Chemotherapy (generalized):

  • Since it is non-selective and affects all rapidly dividing cells, it is very toxic.
  • Chemotherapy only affects active cells during course of treatment (not dormant cancer causing stem cells).

www.ctoam.com

limitations of chemotherapy55
Limitations of chemotherapy

Chemotherapy (generalized):

Angiogenesis occurs directly after treatment.

Chemotherapy can create new DNA mutations that may lead to new cancers.

www.ctoam.com

radiation and chemotherapy
Radiation and chemotherapy

The main difference between radiation and chemotherapy is that radiation is used locally and limited to specific regions of the body, while chemotherapy affects all of the cells in the body.

www.ctoam.com

additional concerns surgery radiation
Additional concerns: Surgery & Radiation

In order for surgery and radiation to be effective, the following concerns need to be addressed:

  • Doctors need to target the stem cell niche as well as the malignant tissue (tumor).
  • Doctors need to ensure they have accurate imaging prior to surgery and treatment to differentiate between normal and tumor tissues.

www.ctoam.com

slide58
In the following sections, we will indicate how these concerns can be addressed using specific types of cancer to illustrate these concepts.

www.ctoam.com

making informed choices surgery
Making informed choices: Surgery

Example 1: Ovarian cancer

  • The stem cell niche is located in the fallopian tubes.
  • Removal of both fallopian tubes and ovaries leads to a 50% reduction in mortality due to ovarian cancer.

www.ctoam.com

making informed choices surgery60
Making informed choices: Surgery

However, despite the significant increase in survival rates with this procedure, a significant amount of surgeries for ovarian cancer remove only one ovary (and sometimes none) due to misconceptions and reasons of surgical convenience.

In order to avoid this outcome, patientsactually need to request the full procedure.

www.ctoam.com

making informed choices radiation
Making informed choices: Radiation

Example 2: Glioblastoma multiform

Glioblastoma multiform is a deadly type of brain cancer.

Even with standard radiation/chemotherapy, most patients relapse after 6 -7 months.

www.ctoam.com

making informed choices radiation62
Making informed choices: Radiation

Example 2: Glioblastoma multiform

  • However, recent clinical trials have shown significant improvements when the radiation is targeted to the stem cell (bilateral subventricular zone).
  • Patients with advanced disease remained tumor free for an average of 15.0 months versus 7.2 months for standard treatment.

www.ctoam.com

making informed choices radiation63
Making informed choices: Radiation

In order to utilize radiation therapy effectively, the maximum dosage needs to be applied to tumor tissue while minimizing doses received to normal surrounding tissue.

www.ctoam.com

making informed choices radiation64
Making informed choices: Radiation

Example 3: Brachytherapy for prostate and breast cancer

  • Insertion of radioactive pins near tumor site.
  • The low dosage of this treatment minimalizes damage to normal tissue and typically decreases the experience of harmful side effects.

www.ctoam.com

making informed choices radiation65
Making informed choices: Radiation

Example 3: Brachytherapy for prostate and breast cancer

Due to low dose, further external beam treatment can still be done at a later date if necessary.

www.ctoam.com

making informed choices radiation66
Making informed choices: Radiation

Example 3: Brachytherapy for prostate and breast cancer

However, since brachytherapy is a form of surgery, it requires a surgeon as well as a radiation oncologist (costly) and, while available, is therefore, not typically encouraged by doctors.

www.ctoam.com

making informed choices imaging
Making informed choices: Imaging

PET/CT

  • Combines CT imaging with positron emission tomography.
  • Shows biological activity within organs and detects cancer in the earliest stages.
  • Uses a cancer-specific glucose solution and a radioactive tracer agent that shows lights up cancerous hot spots.

www.ctoam.com

slide68

Making informed choices: Imaging

Imaging: PET-CT

According to the BC Cancer Agency;

In 87 % of cases in which a patient has had a PET-CT scan, the results of the test lead to changes in the initial decisions made by oncologists for planned cancer treatment.

www.ctoam.com

slide69

Making informed choices: Imaging

Imaging: PET-CT

In other words, without a PET-CT scan, current detection methods are only accurate 13% of the time!

PET-CT not only ensures proper targeting of the tumor during surgery and radiation treatments, it helps avoid over-treatment or under-treatment.

www.ctoam.com

slide70

Making informed choices: Imaging

Imaging: PET-CT

We believe a PET-CT should be conducted before any surgery, radiation or chemotherapy is initiated.

You can initiate this process for yourself and ensure your surgeon has this data before or during your treatment protocol.

www.ctoam.com

slide71

Making informed choices: Imaging

Imaging: PET-CT

The following images illustrate the importance of PET-CT in the diagnosis and treatment of cancer.

The next slide is an example of a standard CT scan with the tumors highlighted in red.

www.ctoam.com

slide73

Making informed choices: Imaging

Imaging: CT

While the CT scan shows changes in growth of a particular mass when scans are done over time, it does not indicate whether these growths are cancerous or not.

The next slide of a PET/CT image graphically illustrates the difference in these two techniques.

www.ctoam.com

slide74
Imaging: PET/CT

www.ctoam.com

slide75

Making informed choices: Imaging

Imaging: PET-CT

As you can see, the tumors light up and are easily distinguished from non-cancerous growths.

This makes it far more likely that all tumors will be targeted properly in surgery and treatment.

www.ctoam.com

additional concerns chemotherapy
Additional concerns: Chemotherapy

Issues:

  • In order for chemotherapy to be effective, we need to accurately determine the dosage and combination of drugs that provides maximal benefits with minimal side effects.
  • This combination will vary from patient to patient depending on the genes involved in your cancer.

www.ctoam.com

additional concerns chemotherapy77
Additional concerns: Chemotherapy

Issues:

  • There are many hundreds of chemotherapy drugs to attend to the great variations in tumor causing gene combinations, and yet, our medical system typically offers the same 2 or 3 chemotherapy drugs for everyone.

www.ctoam.com

additional concerns chemotherapy78
Additional concerns: Chemotherapy

Issues:

  • This means that patients may receive treatment that doesn’t impact (or has limited impact on) their tumor growth and which leads to severe side-effects (typically a symptom of a patient being administered an ineffective/minimally effective form of chemotherapy for their genetic predisposition).

www.ctoam.com

additional concerns chemotherapy79
Additional concerns: Chemotherapy

Issues:

  • It is clear that doing all you can to ensure that you are taking the right mix of chemotherapy drugs for your unique cancer is fundamental to effective treatment, limiting side-effects, and a rapid and longstanding recovery.

www.ctoam.com

additional concerns chemotherapy80
Additional concerns: Chemotherapy

Issues:

  • It is also fundamental, as discussed, that in our treatment of cancer we also the target stem cell niche as well as malignant tissue.
  • This is an important concern as standard chemotherapy drugs do not affect doemant stem cells.

www.ctoam.com

making informed choices diagnostics
Making informed choices: Diagnostics

Chemotherapy Sensitivity Tests:

  • In this test (not typically provided by the medical system) cell sensitivity tests are performed on a patients tumor samples and can identify personalized dose and drug combinations (optimized chemotherapy).

www.ctoam.com

slide82

Making informed choices: Diagnostics

Chemotherapy Sensitivity Tests:

  • Optimized chemotherapy combinations allow for lower doses, less side effects, and faster recovery times.
  • Tests such as these Chemotherapy sensitivity tests can ensure that you get the right combination in the right dose for you.

www.ctoam.com

slide83

Making informed choices: Diagnostics

Imaging and Optimized Chemotherapy:

CTOAM can coordinate your tests for optimized chemotherapy and PET-CT on your behalf. Or, if you prefer, we can also consult with you and educate you on how to arrange these tests for yourself prior to, or during your standard treatment.

www.ctoam.com

clinical trials
Clinical trials:

Clinical trials represent leading-edge medical science. However, less than 5% of adults diagnosed with cancer each year are enrolled in clinical trails.

While there are a number of various treatment approaches being offered through clinical trials, 8 out of 10 patients are not aware that this is a viable option for them.

www.ctoam.com

clinical trials85
Clinical trials
  • In fact:
  • Clinical trials represent leading-edge medical science.
  • Most clinical trials are based on a rational design (they are based on a defined genetic mechanism) and selectively target a genetic signature unique to a particular form of cancer.

www.ctoam.com

benefits of clinical trials
Benefits of clinical trials
  • In order to be offered to the human population, each clinical trial must show that the approach being tested is superior to standard treatment.
  • Patients are also provided with superior imaging and diagnostics not typically offered in public medical facilities.

www.ctoam.com

benefits of clinical trials87
Benefits of clinical trials

Patients can participate in multi-centre clinical trials offered in over 174 countries.

Participation can be done through hospitals, outpatient clinics, or locally through your primary physician.

www.ctoam.com

benefits of clinical trials88
Benefits of clinical trials
  • They do not replace standard treatment, they are a form of adjunct therapy, and as such are offered as an additional treatment to standard treatment.
  • In clinical trials the standard treatment is typically used in place of the placebo (control group).

www.ctoam.com

benefits of clinical trials89
Benefits of clinical trials
  • Clinical Trials Are Free.
  • But best of all, their success depends

on your survival!

www.ctoam.com

benefits of clinical trials90
Benefits of clinical trials

Because research shows that the genes involved in each cancer can vary greatly from person to person, at CTOAM we believe that involving yourself in treatments and clinical trials that directly target the genes triggering your cancer is fundamental to ensuring effective and complete treatment.

www.ctoam.com

benefits of clinical trials91
Benefits of clinical trials

Upon your request CTOAM can conduct personalized research to identify the genes most likely involved in the development of your cancer and supply you with a list of clinical trials, world wide, that are targeting those genes specifically.

We will also arrange for your participation should you choose to explore that treatment option.

www.ctoam.com

nutraceuticals
Nutraceuticals

In this next section, we will show you how you can use nutraceuticals to reduce the ability of your cancer to develop by inhibiting the key genes it is dependent on for its proliferation.

www.ctoam.com

nutraceuticals93
Nutraceuticals

A nutraceutical is a naturally occurring component of a food group that has scientifically proven cancer fighting activity.

www.ctoam.com

nutraceuticals94
Nutraceuticals

Nutraceuticals can be used to regulate cancer-specific pathways and genes during and between treatment regimes.

www.ctoam.com

nutraceuticals95
Nutraceuticals

This means, that unlike standard treatment with radiation and/or chemotherapy alone, the cancer does not have the same freedom to proliferate between treatment regimes because you are dosing yourself with non-toxic nutraceuticals on a daily basis to prevent tumor growth and enhance tumorsupressor gene function.

www.ctoam.com

nutraceuticals96
Nutraceuticals

Nutraceuticals have the ability to continually regulate cancer causing stem cells, unlike toxic drug based approaches.

Nutraceuticals can also enhance cancer cell sensitivity to standard chemotherapy and radiation therapy which improves treatment outcomes.

www.ctoam.com

nutraceuticals97
Nutraceuticals

Nutraceuticals are inexpensive and non-toxic.

Nutraceutical combinations can be used to create a personalized diet based on the unique genetic signature of your cancer.

You can start today to enhance the cancer fighting ability of your body.

www.ctoam.com

using nutraceuticals
Using Nutraceuticals

The following section is an example of how you can use nutraceuticals to target a specific gene involved in a variety of cancers.

www.ctoam.com

nutraceutical based gene targeting pten
Nutraceutical Based Gene Targeting: PTEN

PTEN is a tumour suppressor gene that normally initiates stem cell differentiation.

PTEN is down-regulated (diminished) or mutated in a variety of cancers.

www.ctoam.com

nutraceutical based gene targeting pten100
Nutraceutical Based Gene Targeting: PTEN

Subtle variations in PTEN levels have been proven to determine cancer susceptibility.

In other words, the amount of PTEN in your body can determine your susceptibility to certain cancers.

www.ctoam.com

nutraceutical based gene targeting pten101
Nutraceutical Based Gene Targeting: PTEN

Even a slight decrease in PTEN can result in a significantly elevated cancer risk (illustrated on the next page).

www.ctoam.com

slide102

Nutraceutical Based Gene Targeting: PTEN

PTEN LEVEL CANCER RISK

Normal

100% -

75% -

50% -

25% -

0% -

- This level found in 40% of Breast cancers

PTEN

Level

- This level found in 57% of Breast cancers

- This level found in 75% of Breast cancers

www.ctoam.com

slide103

Nutraceutical Based Gene Targeting: PTEN

You can see, from this chart, that a small decrease in PTEN levels can create a greater chance of the development to cancer.

The good news is, that even a small increase in PTEN levels can reduce your susceptibility to certain cancers!

www.ctoam.com

slide104

Nutraceutical Based Gene Targeting: PTEN

There are a variety of easily accessible Nutraceuticals that can reactivate PTEN:

  • Sulforaphane (broccoli).
  • Genestein (soy).
  • Resveratrol (red wine).
  • EGCG (green tea).
  • Curcumin (tumeric).

www.ctoam.com

slide105
However, clinical trials using single

nutraceuticals have resulted in mixed

results.

Why?

Nutraceutical Based Gene Targeting: PTEN

www.ctoam.com

slide106
One of the largest hurdles in the therapeutic use of nutraceuticals is due to their low bioavailability.

The bioavailability of a nutraceutical refers to its ability to remain in the body at a concentration that has cancer fighting activity.

Nutraceutical Based Gene Targeting: Concerns

www.ctoam.com

slide107
For the vast majority of nutraceuticals, this is not possible through oral administration.

However, recent scientific advancements have revealed synergistic combinations that allow us to achieve cancer fighting amounts through oral administration.

Nutraceutical Based Gene Targeting: Concerns

www.ctoam.com

bioavailability absorbance
Bioavailability: Absorbance
  • Curcumin (tumeric) is not easily absorbed by the body
  • However, nanoparticle-encapsulated curcumin has greatly increased bioavailability.
  • This formulation was shown to inhibit cancer growth and targeted the stem cell fraction of malignant brain tumors.

www.ctoam.com

bioavailability absorbance109
Bioavailability: Absorbance
  • A component of pepper named piperine greatly increases the oral bioavailability of curcumin.
  • Piperineincreases the absorbance of curcumin by 2000 %. This is clearly a substantial difference in the effectiveness of a key nutraceutical.

www.ctoam.com

nutraceuticals issues
Nutraceuticals: Issues

At CTOAM, we believe everyone should know about the value of nutraceuticals in fighting cancer and preventing it, but there are currently two main barriers to this being the case:

1. The scientific research on these substances has not yet made its way to the mainstream medical system or into the hands of alternative practitioners and dieticians.

www.ctoam.com

nutraceuticals issues111
Nutraceuticals: Issues

2. Since nutraceuticals are naturally occurring and can’t be patented, their incredible potential as therapeutic agents has not yet been fully realized because, simply put, there is not much money to be made by pharmaceutical, or medical treatment companies, in encouraging you to eat more broccoli or take some curcumin capsules with pepper.

www.ctoam.com

nutraceuticals issues112
Nutraceuticals: Issues

The low bioavailability of some nutraceuticals and the lack of understanding of some researchers about the ability of certain substances, such as piperine, to enhance bioavailability has further confounded the results of some clinical trials, leading to great misunderstandings about the powerful anti-cancer benefits of nutraceuticals.

www.ctoam.com

nutraceutical issues
Nutraceutical: Issues

Some obvious factors that are affecting the outcome of nutraceutical clinical trials:

Variations in the amount of the nutraceutical used in the different clinical trials.

The strain and type of plant that the nutraceutical is obtained from is not consistent thus the results will naturally vary.

www.ctoam.com

nutraceutical issues114
Nutraceutical: Issues

Some obvious factors that are affecting the outcome of nutraceutical clinical trials:

The diet of the patient is not often being observed for any naturally occuring substances that would enhance or detract from the bioavailability of the substance being tested.

www.ctoam.com

nutraceutical issues115
Nutraceutical: Issues

As an example of the importance of consistency of potency in nutraceutical studies, the following figure shows the different amounts of a cancer fighting nutraceutical (EGCG), found in various strains of green teas.

www.ctoam.com

egcg of various green teas
EGCG of Various Green Teas

EGCG CONTENT (%) TYPE OF GREEN TEA

6% -

5% -

4% -

3% -

2% -

1% -

Sencha Uchiyama

Gyokuro #1

Sencha #1

Sencha #2, Gyokuro #2

Pilo Chun Emperor, Gyokuro #3, Gyokuro #4

Matcha

Yunnan, Yuzan, Paimutan

Meng Ding, Lung Chin

Dong Ding

Pou Chong, Tikuan Yin

nutraceuticals issues117
Nutraceuticals: Issues

You will recall that EGCG has a positive influence on the cancer fighting gene, PTEN.

It is therefore, significant to note that drinking 6 cups of Sencha-Uchiyama results in an equivalent amount of EGCG as drinking 69 cups of Pou Chong or Tikuan Yin green tea!

www.ctoam.com

nutraceuticals summary
Nutraceuticals: Summary

Clearly, effective cancer treatment must include the proper nutraceuticals in the right amount and combination for your body.

You can directly, immediately and inexpensively target oncogenes and tumor suppressor genes and enhance the effectiveness of your treatment when you use nutraceuticals.

www.ctoam.com

nutraceuticals how we can help
Nutraceuticals: How we can help.

CTOAM will provide you with personalized research that ensures you are eating the right amounts and combinations of nutraceuticals to effectively target the genes involved in your cancer.

www.ctoam.com

what we ve learned
What We’ve Learned
  • In this presentation we have explored how cancer develops and the role of genes and stem cells in its development.
  • We have also explored current treatments, their effectiveness and limitations.

www.ctoam.com

what we ve learned121
What We’ve Learned
  • We have reviewed diagnostic and imaging options that have been proven to enhance treatment effectiveness
  • We have reviewed the benefits and misconceptions of clinical trials.

www.ctoam.com

what we ve learned122
What We’ve Learned

We have also explored the incredible value of using nutraceuticals as part of your standard cancer treatment and prevention protocol.

www.ctoam.com

how we can help you
How we can help you

CTOAM exists to ensure you have all the information and support you need to understand the causes of your unique cancer and to access and any and all scientifically supported diagnostic and treatment options that have already been shown to maximize the potential for complete recovery.

www.ctoam.com

how we can help you124
How we can help you

We will also work with your doctor to ensure that they have the information they need (with scientific, peer reviewed references attached) to proceed with the best form of chemotherapy and with any clinical trials that would be most advantageous for the successful treatment of the underlying cause of your cancer.

www.ctoam.com

how we can help you125
How we can help you

Based on personalized genetic research, we will also prepare a special nutraceutical- based diet specifically for you that will target tumor suppressor genes to enhance their functionality while also enhancing the effectiveness of any chemotherapy and radiation treatment you engage in.

www.ctoam.com

how we can help you126
How we can help you

The Personalized options plan (POP):

The most popular of CTOAM’s personalized research services is our POP, Personalized Options Plan.

www.ctoam.com

how we can help you127
How we can help you

The Personalized options plan (POP):

A POP is your personalized cancer research document that identifies the underlying causes of your cancer and then shows you how to target those genes in every aspect of your treatment and diet.

www.ctoam.com

how we can help you128
How we can help you

Personalized options plan (POP):

In your POP we use only peer-reviewed clinical data pertaining to enhanced standard treatments, new approaches to treatment, clinical trials, and nutraceuticals, specific to your form of cancer and your unique genetic and environmental contributors.

www.ctoam.com

how we can help you129
How we can help you

Personalized options plan (POP):

Each POP also includes 4 hours of direct consultation with one of our personal research scientists to ensure that you have the support and understanding that you need to feel confident exploring the treatments and nutraceuticals that we identified as the most beneficial for you.

www.ctoam.com

how we can help you130
How we can help you

When you hire CTOAM, you are hiring your own personal team of experienced cancer researchers to advocate for you and assist you in your treatment and recovery.

We will ensure you are maximizing the potential in every aspect of your treatment.

www.ctoam.com

how we can help you131
How we can help you

Consulting:

We provide personalized treatment consultations and can review your medical records to ensure that you and your healthcare team are aware of any recent advancements in diagnosis, treatment, and nutraceuticals relevant to your specific form of cancer.

www.ctoam.com

how we can help you132
How we can help you

Presentations and Seminars:

Our goal is to educate and inform cancer patients about advances and options in cancer treatment and management.

We provide a variety of presentations and seminars that are tailored to address the specific needs and knowledge level of your group or organization.

www.ctoam.com

how we can help you133
How we can help you

Presentations and Seminars:

We can provide presentations on the

following topics:

Advancements in treatments for a specific form of cancer.

How to create a gene-based nutraceutical diet.

How to access and participate in clinical trials.

www.ctoam.com

how we can help you134
How we can help you

Presentations and Seminars:

Our presentations can be tailored to meet the

needs of:

Medical facilities and doctors.

Cancer support groups.

Community centers.

Health shows and events.

Educational facilities.

www.ctoam.com

thank you
Thank you

We hope you’ve learned a lot from this presentation and we welcome your questions and suggestions.

Please share this presentation with anyone you know who may have received a cancer diagnosis. There is so much that can be done to enhance standard treatment.

www.ctoam.com

thank you136
Thank you

For more information on any of our services and how we can help you, please visit our website or contact us to arrange a free question and answer session with one of our patient support staff.

Phone: (778) 999-5463 Fax: (866) 264-1619

E-mail: [email protected]

www.ctoam.com

ad